• Viikinkaari 5, Biocenter 2

    00790 Helsinki

    Finland

20172022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Description of research and teaching

Research project

PRINT-AID project, PhD in Drug Research (2017-2021)

Supervised by Jari Yli-Kauhaluoma, Kirsi Savijoki and Adyary Fallarero, Faculty of Pharmacy, Division of Pharmaceutical Biosciences, Anti-infective research group, University of Helsinki, Finland

Title of thesis: Identification, mechanistic characterization and chemical optimization of repurposed anti-biofilms

Description: The doctoral project is part of the PRINT-AID network (Marie Sklodowska-Curie Actions, Innovative Training Networks, H2020-MSCA-ITN-2016) and contributes to the main goal of developing a new generation of personalized anti-infective 3D-printed medical devices. The objectives of the project are to identify new anti-biofilms, characterize their mechanism of action and select at least one lead for structural optimization and integration into a 3D-printed medical device. The discovery of new anti-biofilm candidates has been accomplished by high-throughput screening and follow-up studies are currently under way. One key compound has been selected for integration into a device prototype and testing in vivo. In parallel, structural optimization is in course in order to increase its potency and value as an anti-biofilm lead overall.

Tasks:

- Miniaturization and otpmization of an antimicrobial activity screening platform based on in vitro bacterial biofilms staining to 384-well microplates with two bacterial strains, S. aureus and P. aeruginosa.

- High-throughput evaluation of the preventive and destructive antimicrobial activity of libraries of compounds on bacterial biofilms using the optimized screening platform based on combined resazurin and crystal violet staining

- Characterization of the anti-biofilm activity using various techniques (ATP production, LIVE/DEAD staining and confocal microscopy, CFU count, MIC/MBC/MBIC determination with Calgary Biofilm Device, activity determination on numerous collection and clinical bacterial strains, cytotoxicity, etc)

- Investigation of the mode of action of the selected hits (killing kinetic, quorum sensing inhibition, membrane disruption assay, transcriptomics analysis, etc)

Curriculum vitae

Academic Background

PhD in Drug Research (2017 - 2021), University of Helsinki, Finland

MSc in Microbiology-Immunology (2016), Laval University, Quebec City, Canada

BSc in Biomedical sciences (2014), Laval University, Quebec City, Canada

BSc in Biology (2014), Laval University, Quebec City, Canada

 

Publications

Gilbert-Girard S, Reigada I, Savijoki K, Yli-Kauhaluoma J, Fallarero A. Screening of natural compounds identifies ferutinin as an antibacterial and anti-biofilm compound. Biofouling. 2021. 37(7): p. 791-807.

Zore M*, Gilbert-Girard S*, Reigada I, Patel Z J., Savijoki K, Fallarero A, and Yli-Kauhaluoma J. Synthesis and Biological Evaluation of Fingolimod Derivatives as Antibacterial Agents. ACS Omega. 2021. 6(28): p. 18465-18486. (*equal contribution)

Reigada I, San-Martin-Galindo P, Gilbert-Girard S, Chiaro J, Cerullo V, Savijoki K, Nyman T A, Fallarero A, Miettinen I. Surfaceome and exoproteome dynamics in dual-species Pseudomonas aeruginosa and Staphylococcus aureus biofilms. Front Microbiol. 2021. 12: p. 672975.

Gilbert-Girard S, Savijoki K, Yli-Kauhaluoma J, Fallarero A. Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod. Microorganisms. 2020. 8(11): p. 1834.

Gilbert-Girard S, Savijoki K, Yli-Kauhaluoma J, Fallarero A. Optimization of a High-Throughput 384-Well Plate-Based Screening Platform with Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 15442 Biofilms. Int J Molec Sci. 2020. 21(9): p. 3034.

Fedorowicz, J., J. Saczewski, A. Konopacka, K. Waleron, D. Lejnowski, K. Ciura, T. Tomasic, Z. Skok, K. Savijoki, M. Morawska, S. Gilbert-Girard and A. Fallarero (2019). "Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents." Eur J Med Chem 179: 576-590.

Gilbert-Girard, S., Savijoki, K., Montoya, L., Fallarero, A. Assess the cellular viability of Staphylococcus aureus biofilms: PrestoBlue HS and alamarBlue HS reagents for microplate viability assays. Bioprobes 79: Journal of Cell Biology Applications, published by Thermo Fisher Scientific Inc. (http://assets.thermofisher.com/TFS-Assets/BID/Reference-Materials/bioprobes-79-journal.pdf)

Education/Academic qualification

Microbiology-Immunology, Master of Science, Université Laval

1 Sep 201431 Dec 2016

Award Date: 31 Dec 2016

Fields of Science

  • 317 Pharmacy
  • antibiotics
  • biofilm

International and National Collaboration

Publications and projects within past five years.